134 related articles for article (PubMed ID: 34167430)
1. Periprocedural risk factors for incomplete radiofrequency ablation of liver metastases from colorectal cancer: a single-center retrospective analysis.
Fan H; Wang X; Qu J; Lu W; Pang Z; Shao T; Xia J; Wang H; Li G; Zhang Y; Sun J; Yang X
Int J Hyperthermia; 2021; 38(1):985-994. PubMed ID: 34167430
[TBL] [Abstract][Full Text] [Related]
2. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
[TBL] [Abstract][Full Text] [Related]
4. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
[TBL] [Abstract][Full Text] [Related]
5. Volumetric assessment of the periablational safety margin after thermal ablation of colorectal liver metastases.
Laimer G; Jaschke N; Schullian P; Putzer D; Eberle G; Solbiati M; Solbiati L; Goldberg SN; Bale R
Eur Radiol; 2021 Sep; 31(9):6489-6499. PubMed ID: 33447860
[TBL] [Abstract][Full Text] [Related]
6. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A
Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675
[TBL] [Abstract][Full Text] [Related]
7. Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases.
Wang CZ; Yan GX; Xin H; Liu ZY
World J Gastrointest Oncol; 2020 Sep; 12(9):1044-1055. PubMed ID: 33005297
[TBL] [Abstract][Full Text] [Related]
8. Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation.
Zhang G; Liu P; Wang G; He X; Xu L; Wang Y; Li W; Peng W
Discov Med; 2024 Apr; 36(183):765-777. PubMed ID: 38665025
[TBL] [Abstract][Full Text] [Related]
9. Radiomics complements clinical, radiological, and technical features to assess local control of colorectal cancer lung metastases treated with radiofrequency ablation.
Markich R; Palussière J; Catena V; Cazayus M; Fonck M; Bechade D; Buy X; Crombé A
Eur Radiol; 2021 Nov; 31(11):8302-8314. PubMed ID: 33954806
[TBL] [Abstract][Full Text] [Related]
10. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?
Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125
[TBL] [Abstract][Full Text] [Related]
11. Clinical Outcomes and Predictors in Patients With Unresectable Colorectal Cancer Liver Metastases Following Salvage Percutaneous Radiofrequency Ablation: A Single Center Preliminary Experience.
Wang Y; Zhang GY; Xu LC; He XH; Huang HZ; Li GD; Wang YH; Wang GZ; Li WT
Technol Cancer Res Treat; 2020; 19():1533033820963662. PubMed ID: 33034276
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the therapeutic efficacy between systemic chemotherapy with and without radiofrequency ablation for colorectal cancer liver metastases: A propensity score matching study.
Hao W; Jun Z; Yan L; Zhong-Yi Z; Bin-Bin J; Gui-Ju L; Wei Y; Lin S; Kun Y
Br J Radiol; 2023 Aug; 96(1148):20221195. PubMed ID: 37191629
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
14. Predictive nomograms of repeat intrahepatic recurrence and overall survival after radiofrequency ablation of recurrent colorectal liver metastases.
Wang JC; Jiang BB; Zhang ZY; Liu YH; Shao LJ; Wang S; Yang W; Wu W; Yan K
Int J Hyperthermia; 2024; 41(1):2323152. PubMed ID: 38465646
[TBL] [Abstract][Full Text] [Related]
15. [Radiofrequency Ablation for Colorectal Liver Metastases].
Nakajima T; Aihara T; Ikuta S; Kusunoki K; Akatsuka M; Kitamura Y; Mitsufuji S; Ichise N; Hamano I; Okamoto R; Nakamoto Y; Kimura F; Yanagi H; Yamanaka N
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1791-1793. PubMed ID: 30692355
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation for early hepatocellular carcinoma: risk factors for survival.
Kikuchi L; Menezes M; Chagas AL; Tani CM; Alencar RS; Diniz MA; Alves VA; D'Albuquerque LA; Carrilho FJ
World J Gastroenterol; 2014 Feb; 20(6):1585-93. PubMed ID: 24587635
[TBL] [Abstract][Full Text] [Related]
17. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
[TBL] [Abstract][Full Text] [Related]
18. Patterns of complications following intraoperative radiofrequency ablation for liver metastases.
Desolneux G; Vara J; Razafindratsira T; Isambert M; Brouste V; McKelvie-Sebileau P; Evrard S
HPB (Oxford); 2014 Nov; 16(11):1002-8. PubMed ID: 24830798
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte-to-monocyte ratio predicts survival after radiofrequency ablation for colorectal liver metastases.
Facciorusso A; Del Prete V; Crucinio N; Serviddio G; Vendemiale G; Muscatiello N
World J Gastroenterol; 2016 Apr; 22(16):4211-8. PubMed ID: 27122671
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
Najafi A; de Baere T; Purenne E; Bayar A; Al Ahmar M; Delpla A; Roux C; Madani K; Assouline J; Deschamps F; Tselikas L
Eur Radiol; 2021 Jul; 31(7):5361-5369. PubMed ID: 33474569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
